 LexaGene Holdings Inc OTCQB:LXXGF CVE:LXG FRA:5XS2 told investors that it continues to systematically advance its MiQLab System to meet the US Food and Drug Administrations FDA criteria for Emergency Use Authorization EUA, including passing electrical safety testing and ship testing. The FDA EUA process requires novel diagnostic devices to undergo a substantial amount of complex design control and testing, the company said, and all functions for critical system operation must be validated and submitted as part of the process. 